# OpenAI acquires Orchestra Bio to build AI agents that speed up drug development

**Published:** October 21, 2026
**Author:** Manuel Uth
**Source:** The Decoder
**Language:** en-US
**HTML:** https://aiqazaqstan.com/en/articles/openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-deve

OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to…

> From the original source: **The Decoder**
> [Read full article at The Decoder](https://the-decoder.com/openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-development/)

**Tags:** #OpenAI

---

*AI Qazaqstan — non-commercial informational portal about AI in Kazakhstan. Machine translations and summaries are AI-generated.*